| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jan 07, 2026 | Sale | $72.23 | 1,974 | 142,582 | 63,832 | Jan 09, 2026, 05:12 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Aug 06, 2025 | Sale | $42.73 | 30,914 | 1,320,844 | 65,806 | Aug 15, 2025, 04:09 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Mar 20, 2025 | Sale | $31.06 | 7,935 | 246,425 | 96,720 | Mar 21, 2025, 06:38 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jan 21, 2025 | Sale | $28.59 | 3,287 | 93,985 | 106,320 | Jan 23, 2025, 08:15 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Dec 18, 2024 | Sale | $32.66 | 11,151 | 364,192 | 82,942 | Dec 19, 2024, 06:16 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Nov 06, 2024 | Sale | $45.56 | 106,319 | 4,843,979 | 94,093 | Nov 08, 2024, 04:50 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Nov 06, 2024 | Option/RSU Exercise | $8.43 | 79,057 | 666,064 | 159,275 | Nov 08, 2024, 04:50 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Sep 23, 2024 | Sale | $44.00 | 11,510 | 506,440 | 96,355 | Sep 23, 2024, 08:59 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jun 18, 2024 | Sale | $39.13 | 11,228 | 439,345 | 57,865 | Jun 20, 2024, 06:48 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jun 12, 2024 | Option/RSU Exercise | $8.82 | 104,245 | 919,441 | 148,338 | Jun 14, 2024, 07:07 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jun 12, 2024 | Sale | $35.72 | 104,245 | 3,723,142 | 44,093 | Jun 14, 2024, 07:07 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | May 14, 2024 | Option/RSU Exercise | $8.82 | 75,000 | 661,500 | 119,093 | May 16, 2024, 06:25 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | May 14, 2024 | Sale | $28.28 | 75,000 | 2,121,045 | 44,093 | May 16, 2024, 06:25 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Mar 13, 2024 | Option/RSU Exercise | $8.82 | 40,000 | 352,800 | 84,093 | Mar 15, 2024, 04:12 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Mar 13, 2024 | Sale | $24.52 | 40,000 | 980,760 | 44,093 | Mar 15, 2024, 04:12 PM | |
| RNA | Avidity Biosciences, Inc. | Michael F. Maclean | Chief Financial Officer | Jan 22, 2024 | Sale | $10.13 | 1,616 | 16,370 | 16,884 | Jan 23, 2024, 03:11 PM | |
| BIIB | BIOGEN IDEC INC. | Michael F. Maclean | SVP, Chief Accounting Officer | Oct 01, 2010 | Tax Payment (Shares) | $56.53 | 953 | 53,873 | 10,681 | Oct 04, 2010, 04:14 PM | |
| BIIB | BIOGEN IDEC INC. | Michael F. Maclean | SVP, Chief Accounting Officer | Aug 02, 2010 | Sale | $56.85 | 9,542 | 542,457 | 20,494 | Aug 03, 2010, 04:03 PM | |
| BIIB | BIOGEN IDEC INC. | Michael F. Maclean | SVP, Chief Accounting Officer | Aug 02, 2010 | Sale | $56.85 | 9,542 | 542,457 | 20,494 | Aug 03, 2010, 04:03 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More